Amphastar Pharmaceuticals is a recognized pharmaceutical company that uses state-of-the-art, cGMP-compliant facilities to develop, manufacture, and market biopharmaceutical injectable, intranasal, and inhalation products.

 

In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities in the United States, China, and Europe, along with a state-of-the-art New Drug Research Center.

 

As a commitment to high quality, all Amphastar finished products are manufactured in the United States.

Amphastar Pharmaceuticals, Inc.

Par Pharmaceutical Companies is a manufacturer and distributor of generic pharmaceutical products.

Par Pharmaceutical Companies

AbbVie is a global biopharmaceutical company focusing on research and development of innovative treatments.

AbbVie

Cipla is a global pharmaceutical company that develops and manufactures a wide range of healthcare products.

Cipla

GSK is a science-led global healthcare company with a special focus on pharmaceuticals, vaccines, and consumer healthcare products.

Sandoz International is a global leader in generic pharmaceuticals and biosimilars.

Sandoz International

Amphastar Pharmaceuticals is a biopharmaceutical company focused on developing, manufacturing, and marketing injectable, intranasal, and inhalation products, as well as complex medications, innovative drug delivery systems, and proprietary products and technological platforms.

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	May 1, 2024 11:28 AM	6e4ae54b
public peers	general	May 1, 2024 11:28 AM	a3820b6c
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 1, 2024 11:28 AM	8f949e9d
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	d3c1676a
crunchbase profile	general
li profile	general	May 1, 2024 11:28 AM	ebbe779f
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 1, 2024 11:28 AM	ef630a42
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:AMPHASTAR

Amphastar Pharmaceuticals

Last Close

44.55

22/11 21:00

Market Cap

1.83B

Beta: -

Volume Today

394.77K

Avg: -